Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

Article Endocrinology & Metabolism

Elevated Plasma Branched-Chain Amino Acid Levels Correlate With Type 2 Diabetes-Related Metabolic Disturbances

Froukje Vanweert et al.

Summary: Patients with type 2 diabetes mellitus have elevated plasma branched-chain amino acid levels, which may be partly due to low mitochondrial oxidative capacity and compromised whole-body leucine oxidation rate.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

Romina Lomonaco et al.

Summary: This study assessed the prevalence of NAFLD and liver fibrosis in patients with type 2 diabetes mellitus, revealing that at least 15% of patients with T2DM and NAFLD have moderate-to-advanced fibrosis. Screening for liver disease can be enhanced using imaging and plasma diagnostic panels, as AST/ALT alone are inadequate as initial screening markers.

DIABETES CARE (2021)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

SGLT2 inhibitors in people with and without T2DM

Kamlesh Khunti

Summary: Heart failure and chronic kidney disease are common causes of morbidity and mortality in patients with type 2 diabetes. The benefits of sodium-glucose co-transporter 2 inhibitors on cardiovascular events, cardiovascular deaths, hospitalization for heart failure, and renal outcomes have been confirmed in cardiovascular outcome trials, and now extend to individuals with or without type 2 diabetes.

NATURE REVIEWS ENDOCRINOLOGY (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes

Hongyan Liu et al.

Summary: The study found that empagliflozin treatment in participants with type 1 diabetes resulted in increased lipid and TCA cycle metabolites, indicating a shift in metabolic substrate use and improved mitochondrial function. These effects lead to more efficient energy production and may contribute to end-organ protection by alleviating local hypoxia and oxidative stress.

DIABETES OBESITY & METABOLISM (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Fatty acid metabolism in the progression and resolution of CNS disorders

Jeroen F. J. Bogie et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

添加到收藏夹

Review Medicine, General & Internal

Role of gut microbiota in type 2 diabetes pathophysiology

Manoj Gurung et al.

EBIOMEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Metabolomics and Proteomics in Type 2 Diabetes

Zsu-Zsu Chen et al.

CIRCULATION RESEARCH (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced Obese Mice

Xiaodong Sun et al.

DIABETES (2020)

添加到收藏夹

Article Cell Biology

FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes

Dan Yan et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Inhibiting fatty acid oxidation promotes cardiomyocyte proliferation

Gregory B. Lim

NATURE REVIEWS CARDIOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Empagliflozin improves left ventricular diastolic function of db/db mice

Julia Moellmann et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

添加到收藏夹

Article Medicine, General & Internal

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Milton Packer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Chemistry, Medicinal

SGLT2 Inhibitors: A Novel Player in the Treatment and Prevention of Diabetic Cardiomyopathy

Na Li et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Diabetic Cardiomyopathy What Is It and Can It Be Fixed?

Wolfgang H. Dillmann

CIRCULATION RESEARCH (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Plasma Amino Acids and Incident Type 2 Diabetes in Patients With Coronary Artery Disease

Adrian McCann et al.

DIABETES CARE (2019)

添加到收藏夹

Review Nutrition & Dietetics

Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes

Amelie I. S. Sobczak et al.

NUTRIENTS (2019)

添加到收藏夹

Article Endocrinology & Metabolism

Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA-REG OUTCOMEA® trial

Takashi Kadowaki et al.

JOURNAL OF DIABETES INVESTIGATION (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

HMDB 4.0: the human metabolome database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease

David Hojland Ipsen et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

添加到收藏夹

Article Endocrinology & Metabolism

Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)

Mohammad Shafi Kuchay et al.

DIABETES CARE (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis

Jasmine Chong et al.

NUCLEIC ACIDS RESEARCH (2018)

添加到收藏夹

Review Endocrinology & Metabolism

Precision medicine in the management of type 2 diabetes

Anna L. Gloyn et al.

LANCET DIABETES & ENDOCRINOLOGY (2018)

添加到收藏夹

Article Chemistry, Analytical

Lipidomic Profiling on Oxidized Phospholipids in Type 2 Diabetes Mellitus Model Zebrafish

Zhen Chen et al.

ANALYTICAL SCIENCES (2018)

添加到收藏夹

Review Cell Biology

Metabolites as regulators of insulin sensitivity and metabolism

Qin Yang et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

添加到收藏夹

Article Endocrinology & Metabolism

Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial

Cristina Razquin et al.

DIABETES CARE (2018)

添加到收藏夹

Review Endocrinology & Metabolism

Sphingolipids and phospholipids in insulin resistance and related metabolic disorders

Peter J. Meikle et al.

NATURE REVIEWS ENDOCRINOLOGY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

KEGG: new perspectives on genomes, pathways, diseases and drugs

Minoru Kanehisa et al.

NUCLEIC ACIDS RESEARCH (2017)

添加到收藏夹

Article Chemistry, Analytical

Metabolomic Profiling of Anionic Metabolites in Head and Neck Cancer Cells by Capillary Ion Chromatography with Orbitrap Mass Spectrometry

Junhua Wang et al.

ANALYTICAL CHEMISTRY (2014)

添加到收藏夹

Review Pharmacology & Pharmacy

Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy

N. Fillmore et al.

BRITISH JOURNAL OF PHARMACOLOGY (2014)

添加到收藏夹

Article Oncology

Cancer metabolism: fatty acid oxidation in the limelight

Arkaitz Carracedo et al.

NATURE REVIEWS CANCER (2013)

添加到收藏夹

Review Physiology

Myocardial Fatty Acid Metabolism in Health and Disease

Gary D. Lopaschuk et al.

PHYSIOLOGICAL REVIEWS (2010)

添加到收藏夹

Metabolomics study reveals the alteration of fatty acid oxidation in the hearts of diabetic mice by empagliflozin

相关参考文献

导出引文

分享论文